FIELD: chemistry.
SUBSTANCE: invention concerns compounds of the formula (Ia) and their application in radiological pharmaceutical compositions for linking to receptors associated with angiogenesis.
EFFECT: possible application in diagnostics or therapy, eg for malignant or cardiac diseases, endometriosis, inflammatory diseases, rheumatoid arthritis and sarcoma Kaposi.
Title | Year | Author | Number |
---|---|---|---|
PEPTIDE-BASED COMPOUNDS FOR DIRECTED TRANSPORT TO INTEGRIN RECEPTORS | 2002 |
|
RU2303042C2 |
RADIOACTIVE ISOTOPE-LABELLED CONJUGATES OF RGD-CONTAINING PEPTIDES AND METHODS OF OBTAINING SAID CONJUGATES USING CLICK CHEMISTRY | 2005 |
|
RU2419627C2 |
PEPTIDE COMPOUNDS | 2005 |
|
RU2393167C2 |
DIAGNOSTIC COMPOUNDS | 2005 |
|
RU2396272C9 |
VISUALISATION TECHNIQUE | 2008 |
|
RU2505316C2 |
MARKED PEPTIDES BINDING HEPATOCYTE GROWTH FACTOR (HGF) FOR VISUALISATION | 2008 |
|
RU2473361C9 |
PEPTIDE COMPOSITION OF RADIOACTIVE INDICATORS | 2011 |
|
RU2594167C2 |
CONTRAST AGENT AIMED AT UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR | 2005 |
|
RU2394837C2 |
CYCLIC OCTAPEPTIDE, RADIOPHARMACEUTICAL AGENT BASED THEREON AND METHOD OF USING RADIOPHARMACEUTICAL AGENT TO PRODUCE MEDICINAL (PHARMACEUTICAL) AGENTS FOR TREATING NEOPLASMS EXPRESSING SOMATOSTATIN RECEPTORS | 2013 |
|
RU2528414C1 |
OCTAPEPTIDE FOR PRODUCING RADIOTRACERS, RADIOTRACER BASED THEREON METHOD OF DIAGNOSING TUMOURS, EXPRESSING SOMATOSTATIN RECEPTORS | 2011 |
|
RU2457215C1 |
Authors
Dates
2009-05-20—Published
2004-07-21—Filed